Brief: Cipher Pharma And Italmex Pharma Announce Exclusive Distribution Agreement For Isotretinoin Product In Mexico
Jan 9 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS AND ITALMEX PHARMA ANNOUNCE
EXCLUSIVE
DISTRIBUTION AGREEMENT FOR ISOTRETINOIN PRODUCT IN MEXICO
* CIPHER PHARMACEUTICALS INC - CO ENTERED INTO AN
EXCLUSIVE
DISTRIBUTION AND SUPPLY AGREEMENT WITH ITALMEX PHARMA S.A
* CIPHER PHARMACEUTICALS INC - DEAL UNDER WHICH CO GRANTED
ITALMEX EXCLUSIVE RIGHTS TO MARKET, SELL,DISTRIBUTE CO'S
ISOTRETINOIN PRODUCT IN MEXICO
Source text for Eikon: ID:nCNWC2WgVa
Further company coverage: CPH.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million